Cost and effectiveness of ciprofloxacin + hydrocortisone versus neomycin + polymyxin B + hydrocortisone in France for the treatment of acute otitis externa

References

• Garabedian EN, Bobin S, Monteil JP et al. ORL de l’enfant. College Medecine et Sciences, Flammarion Eds, 1996.
   Google Scholar
• Legent F, Bordure P. Pathologie du conduit auditif externe. La Revue du Praticien 1995; 9: 38–45.
   Google Scholar
• Portman M, Portman D. ORL. Paris: College Abrégés Masson Eds, 1996.
   Google Scholar
• Dibb WL. The normal microbial flora of the outer ear canal in healthy Norwegian individuals. NPIH Annuals 1990; 13: 11–16.
   Google Scholar
• Cassisi N, Cohn A, Davidson T et al. Diffuse otitis externa: clinical and microbiological findings in the course of a multicenter study on new otic solution. Annals of Otology, Rhinology and Laryngology 1977; 86 (Suppl. 39): 1–16.
   Google Scholar
• Poncet JL, Verdalle E, Roguet et al. Otites externes. Aspects particuliers en milieu militaire. Journal Français D’Otho-Rhino- Laryngologie 1996; 45: 383–394.
   Google Scholar
• Bonnet E, Gallais H. Pathologies infectieuses estivales en Provence. Enquète réalisée pendant l’été 1992 par l’Institut d’Infectiologie de Marseille- Provence. Medecine et Maladies Infectieuses 1994; 24: 828–843.
   Google Scholar
• Noyon P, Portmann D. L’otite externe. Revue de Laryngologie Otologie Rhinologie 1997; 118: 213–220.
   PubMedGoogle Scholar
• Freche C. Etude de l’efficacité et de la tolérance d’Auriculum dans l’otite externe diffuse d’origine bactérienne et/ou mycosique, résistante au premier traitement. Revue de la Société Française d’ORL 1997; 43: 43–55.
   Google Scholar
• Clark WB, Brook I, Bianki D et al. Microbiology of otitis externa. Otolarynology Clark WB, Brook I Head and Neck Surgery 1997; 116: 23–25.
   Google Scholar
• Brook I, Frazier EH, Thompson DH. Aerobic and anaerobic microbiology of external otitis. Clinical Infectious Diseases 1992; 15: 955–958.
   PubMed Web of Science ®Google Scholar
• Jones RN, Milazzo J, Seidlin M. Ofloxaxin otic solution for treatment of otitis externa in children and adults. Archives of Otolaryngology — Head and Neck Surgery 1997; 123: 1193–1200.
   PubMed Web of Science ®Google Scholar
• Piccirillo JF, Parnes SM. Ciprofloxacin for the treatment of chronic ear disease. Laryngoscope 1989; 99: 510–513.
   PubMed Web of Science ®Google Scholar
• Dibb WL. Microbial aetiology of otitis externa. Journal of Infection 1991; 2: 233–239.
   Google Scholar
• Van Asperten IA, De Rover CM, Schijven JF et al. Risk of externa otitis after swimming in recreational fresh water lakes containing Pseudomonas aeruginosa. British Medical Journal 1995; 311: 1407–1410.
   PubMedGoogle Scholar
• Ruth M, Ekstrom T, Aberg B, et al. A clinical comparison of hydrocortisone butyrate with oxytetracycline/ hydrocortisone acetate-polymyxin B in the local treatment of acute otitis external. European Archives of Otothinolaryngology 1990; 247: 77–80.
   Google Scholar
• Russell JD et al. What causes acute otitis externa? Journal of Laryngology and Otology 1993; 107: 898–901.
   PubMed Web of Science ®Google Scholar
• Bayo M, Agut M, Calvo MA. Otitis externa infecciosas: etilogica en el area de Terrassa, metodos de cultivo y consideraciones sobre la otomicosis. Microbiologia 1994; 10: 279–284.
   PubMedGoogle Scholar
• Bojrad DI, Bruderly T, Abdulrazzak Y. Otitis externa. Otolaryngologic Clinics of North America 1996; 29: 761–782.
   PubMed Web of Science ®Google Scholar
• Aguzzoli F, Le Fur P, Sermet C. Clientèle et motifs de recours en médecine libérale. Rapport CREDES N° 1008 et 1008 bis, 1994.
   Google Scholar
• International Medical Statistics, Paris, 2000.
   Google Scholar
• Legent F, Fleury P, Narcy P et al. ORL, pathologie cervico-faciale. Masson Eds, 1996.
   Google Scholar
• Vidal, 2000. Paris: Edition du Vidal.
   Google Scholar
• Miro N. Controlled multicenter study on chronic suppurative otitis media treated with topical applications of ciprofloxacin 0.2% solution single-dose containers or combination of polymixin B, neomycin and hydrocortisone suspension. Otoralyngology-Head and Neck Surgery 2000; 123: 617–623.
   Google Scholar
• Dohar JE, Alper CM, Rose EA et al. Treatment of chronic suppurative otitis media with topical ciprofloxacin. Annals of Otology, Rhinology & Laryngology 1998; 107: 867–871.
   Web of Science ®Google Scholar
• Wintermeyer SM, Nahata MC. Chronic suppurative otitis media. Annals of Pharmacotherapy 1994; 28: 1089–1099.
   PubMed Web of Science ®Google Scholar
• Ruddy J, Bickerton RC. Optimum management of the discharging ear. Drugs 1992; 43: 219–235.
   PubMed Web of Science ®Google Scholar
• Lafuma A, Fagnani F, Berdeaux G. Cost-effectiveness of ciprofloxacin + hydrocortisone versus neomycin + polymixin + hydrocortisone in the treatment of acute otitis externa. Values in Health 2000; 3: 342.
   Google Scholar
• Pistorius B, Westberry K, Drehobl M et al and the Otitis Externa Study Group. Prospective randomised comparative trial of ciprofloxacin otic drops with or without hydrocortisone vs. polymixin-B- neomycin-hydrocortisone otic suspension in the treatment of acute diffuse otitis externe. Infectious Diseases in Clinical Practice 1999; 8: 387–395.
   Web of Science ®Google Scholar
• Guide Rosenwald. Annuaire du corps médical français. Paris: L’annuaire du Médecin, 1997.
   Google Scholar
• Guidelines and Recommendations for French Pharmaco-Economic Studies. Journal d’Economie Médicale 1998; 16: 353–372.
   Google Scholar
• Nomenclature générale des actes professionnels. Nomenclature des actes professionnels. Paris: Union des caisses nationales de Sécurité Sociale, 2000
   Google Scholar
• Tarif Interministériel des Prestations Sanitaires. Paris: UCANSS, 2000.
   Google Scholar
• Dumesnil S et al. Santé, soins et protection sociale en 1997, N°1255, Février 1999, CREDES
   Google Scholar
• Journal officiel des Communautés Européennes. Règlement CE N° 2866/98 du conseil du 31 Décembre 1998 concernant les taux de conversions entre l’Euro et les monnaies des états membres adoptant l’euro.
   Google Scholar
• Collège des économistes de la santé. Rapport d’une commission d’experts présidée par le Pr Emile Lévy, sous l’égide du collège des économistes de la santé. Recommandations de bonnes pratiques des méthodes d’évaluation économique des stratégies thérapeutiques. Paris, 1997.
   Google Scholar
• Points to be considered on Bio-statistical/ Methodological issues arising from recent CPMP discussions on licensing applications: superiority, non inferiority and equivalence. London, 23rd September, 1999
   Google Scholar
• Le secteur de l’ophtalmologie pharmaceutique. Revue de l’ophtalmologie Française 1999; 117: 52–55.
   Google Scholar
• Timon CI, O’Dwyer T. Diagnosis, complications, and treatment of malignant otitis externa. Irish Medical Journal 1989; 82: 30–31.
   PubMedGoogle Scholar
• Hickham M, Amedee RG Malignant otitis externa. La State Med Soc 1996; 148: 511–513.
   PubMedGoogle Scholar
• Hickey SA, Eykyn SJ. Successful treatment of malignant otitis externa with oral ciprofloxacin. Journal of Infection 1990; 20: 90.
   PubMed Web of Science ®Google Scholar
• Giamarellou H Malignant otitis externa: the therapeutic evolution of a lethal infection. Journal of Antimicrobial Chemotherapy 1992; 30: 745–751.
   PubMed Web of Science ®Google Scholar
• Barrow HN, Levenson MJ. Necrotizing ‘malignant’ external otitis caused by Staphylococcus epidermidis. Archives of Otolaryngology-Head and Neck Surgery 1992; 118: 94–96.
   PubMedGoogle Scholar